Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New therapeutic approaches for cystic fibrosis lung disease.

× No keyword cloud information.

70 in total

1. Pathology of cystic fibrosis review of the literature and comparison with 146 autopsied cases.

Authors: E H Oppenheimer; J R Esterly
Journal: Perspect Pediatr Pathol Date: 1975

Review 2. Macrolides in the respiratory tract in cystic fibrosis.

Authors: Adam Jaffé; Mark Rosenthal
Journal: J R Soc Med Date: 2002 Impact factor: 5.344

Review 3. Pathogenesis of cystic fibrosis.

Authors: C Koch; N Høiby
Journal: Lancet Date: 1993-04-24 Impact factor: 79.321

4. Protection against pulmonary infection with Pseudomonas aeruginosa following immunization with P. aeruginosa-pulsed dendritic cells.

Authors: S Worgall; T Kikuchi; R Singh; K Martushova; L Lande; R G Crystal
Journal: Infect Immun Date: 2001-07 Impact factor: 3.441

5. Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis.

Authors: J P Clancy; Z Bebök; F Ruiz; C King; J Jones; L Walker; H Greer; J Hong; L Wing; M Macaluso; R Lyrene; E J Sorscher; D M Bedwell
Journal: Am J Respir Crit Care Med Date: 2001-06 Impact factor: 21.405

6. Quenching quorum-sensing-dependent bacterial infection by an N-acyl homoserine lactonase.

Authors: Y H Dong; L H Wang; J L Xu; H B Zhang; X F Zhang; L H Zhang
Journal: Nature Date: 2001-06-14 Impact factor: 49.962

Review 7. Gene therapy for cystic fibrosis.

Authors: J C Davies; D M Geddes; E W Alton
Journal: J Gene Med Date: 2001 Sep-Oct Impact factor: 4.565

New therapeutic approaches for cystic fibrosis lung disease.

1. Pathology of cystic fibrosis review of the literature and comparison with 146 autopsied cases.

Review 2. Macrolides in the respiratory tract in cystic fibrosis.

Review 3. Pathogenesis of cystic fibrosis.

4. Protection against pulmonary infection with Pseudomonas aeruginosa following immunization with P. aeruginosa-pulsed dendritic cells.

5. Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis.

6. Quenching quorum-sensing-dependent bacterial infection by an N-acyl homoserine lactonase.

Review 7. Gene therapy for cystic fibrosis.

8. Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells.

9. Cystic fibrosis: current survival and population estimates to the year 2000.

10. No added benefit from nebulized amiloride in patients with cystic fibrosis.

Review 1. Cystic fibrosis in adults: current and future management strategies.